Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer
- PMID: 32119855
- DOI: 10.1016/j.athoracsur.2020.01.020
Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer
Abstract
Background: The oncologic efficacy of segmentectomy is controversial. We compared long-term survival in clinical stage IA (T1N0) Medicare patients undergoing lobectomy and segmentectomy in The Society of Thoracic Surgeons database.
Methods: The Society of Thoracic Surgeons General Thoracic Surgery Database was linked to Medicare data in 14,286 lung cancer patients who underwent segmentectomy (n = 1654) or lobectomy (n = 12,632) for clinical stage IA disease from 2002 to 2015. Cox regression was used to create a long-term survival model. Patients were then propensity matched on demographic and clinical variables to derive matched pairs.
Results: In Cox modeling segmentectomy was associated with survival similar to lobectomy in the entire cohort (hazard ratio, 1.04; 95% confidence interval, 0.89-1.20; P = .64) and in the matched subcohort. A subanalysis restricted to the 2009 to 2015 population (n = 11,811), when T1a tumors were specified and positron emission tomography results and mediastinal staging procedures were accurately recorded in the database, also showed that segmentectomy and lobectomy continue to have similar survival (hazard ratio, 1.00; 95% confidence interval, 0.87-1.16). Subanalysis of the pathologic N0 patients demonstrated the same results.
Conclusions: Lobectomy and segmentectomy for early-stage lung cancer are equally effective treatments with similar survival. Surgeons from The Society of Thoracic Surgeons database appear to be selecting patients appropriately for sublobar procedures.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008. Epub 2013 Mar 8. J Thorac Cardiovasc Surg. 2013. PMID: 23477694
-
Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.Ann Thorac Surg. 2018 May;105(5):1483-1491. doi: 10.1016/j.athoracsur.2018.01.032. Epub 2018 Feb 17. Ann Thorac Surg. 2018. PMID: 29462591
-
Comparison of Segmentectomy and Lobectomy in Stage IA Adenocarcinomas.J Thorac Oncol. 2017 May;12(5):890-896. doi: 10.1016/j.jtho.2017.01.012. Epub 2017 Jan 20. J Thorac Oncol. 2017. PMID: 28111235
-
Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?Gen Thorac Cardiovasc Surg. 2020 Jul;68(7):703-706. doi: 10.1007/s11748-019-01219-y. Epub 2019 Nov 6. Gen Thorac Cardiovasc Surg. 2020. PMID: 31691886 Review.
-
Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis.Eur J Cardiothorac Surg. 2014 Jul;46(1):1-7. doi: 10.1093/ejcts/ezt554. Epub 2013 Dec 8. Eur J Cardiothorac Surg. 2014. PMID: 24321996 Review.
Cited by
-
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.J Thorac Dis. 2022 Jun;14(6):2357-2386. doi: 10.21037/jtd-21-1824. J Thorac Dis. 2022. PMID: 35813747 Free PMC article. Review.
-
Optimal therapeutic strategy for non-small cell lung cancer with thoracic extrathoracic metastasis: a study based on SEER database.J Thorac Dis. 2024 Feb 29;16(2):1021-1033. doi: 10.21037/jtd-23-516. Epub 2024 Feb 22. J Thorac Dis. 2024. PMID: 38505038 Free PMC article.
-
Defining the learning curve of robotic portal segmentectomy in small pulmonary lesions: a prospective observational study.J Robot Surg. 2023 Aug;17(4):1477-1484. doi: 10.1007/s11701-023-01545-7. Epub 2023 Feb 14. J Robot Surg. 2023. PMID: 36787021
-
Local control and short-term outcomes after video-assisted thoracoscopic surgery segmentectomy versus lobectomy for pT1c pN0 non-small-cell lung cancer.Interdiscip Cardiovasc Thorac Surg. 2023 Feb 6;36(2):ivad037. doi: 10.1093/icvts/ivad037. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 36856745 Free PMC article.
-
Long-term outcomes and risk factors for recurrence after lung segmentectomy.Interdiscip Cardiovasc Thorac Surg. 2024 Jul 3;39(1):ivae125. doi: 10.1093/icvts/ivae125. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38950179 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical